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Regulators of G protein signaling (RGS proteins) interact
with Gq and Gi and accelerate GTPase activity. These
proteins have been characterized only within the past few
years, so our understanding of their importance is still pre-
liminary. We examined the effect of oxytocin on RGS2 mRNA
expression to help determine the role of RGS proteins in
oxytocin signaling in human myometrial cells in primary
culture. Oxytocin increased RGS2 mRNA concentration max-
imally by 1 or 2 h in a dose-dependent and agonist-specific
manner. RGS2 mRNA levels were also elevated by treatment
with Ca2 ionophore, phorbol ester, or forskolin. Oxytocin’s
effects were completely inhibited by an intracellular Ca2
chelator and partially blocked by a protein kinase C inhibi-
tor, indicating that intracellular Ca2 concentration is the
primary signal for oxytocin elevation of RGS2 mRNA levels.
Use of pharmacological inhibitors indicated that part of oxy-
tocin-stimulated RGS2 mRNA expression is mediated by
Gi/tyrosine kinase activities. Although oxytocin does not
stimulate increases in intracellular cAMP concentration,
agents that elevate intracellular cAMP concentrations and
cause myometrial relaxation may possibly cause heterolo-
gous desensitization to oxytocin via RGS2 expression. These
results suggest that RGS2 may be important in regulating
the myometrial response to oxytocin.
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PROTEINS TERMED REGULATORS of G protein signaling
(RGS proteins) are a diverse multiprotein family that
interacts with activated G subunits to block signaling
by Gi and/or Gq classes of G proteins (12). The RGS
protein binding results in accelerated hydrolysis of
G-bound GTP. As part of the general class of GTPase-
activating proteins, RGS proteins may be important for
turning off many G protein-mediated physiological re-
sponses, accounting for attenuated responses or, in the
extreme, what appears to be uncoupling of G protein
activity from liganded receptors. GTPase-activating
proteins have been characterized only within the past
few years, so our understanding of their importance is
still rudimentary. Several RGS mRNAs are constitu-
tively expressed at high levels (8, 22), suggesting that
the corresponding proteins might be readily available
for the acute desensitization of signaling. In contrast,
RGS2 mRNA levels are typically low in resting cells
but are upregulated for several hours after stimulation
by various agents in different cell types (11, 13, 14, 19,
22, 26). RGS2 mRNA is presumably synthesized in
response to an initial stimulus and then blocks subse-
quent hormone-signaling events.
Oxytocin (OT) is a G protein-coupled receptor ago-
nist that stimulates uterine smooth muscle contrac-
tion. Human myometrial cells in culture express OT
receptors, and, although these cells are not in an ap-
propriate environment to contract, they possess signal
pathways involved in the stimulation of contraction.
Thus myosin light chain kinase activity can be acti-
vated in myometrial smooth muscle cells by elevation
of intracellular Ca2 concentrations (2). OT also stim-
ulates an increase in prostacyclin synthesis by a G
protein-sensitive (pertussis toxin-inhibitable) pathway
in cultured human myometrial cells (20). RGS2 pre-
sumably is expressed in all cell types, but nothing is
known of its function in uterine smooth muscle cells.
We have shown in the present studies that OT stimu-
lates increased expression of RGS2 mRNA in human
myometrial cells in primary culture and elucidated the
major signal pathways involved.
MATERIALS AND METHODS
Reagents. Reagents were obtained from the following
sources: OT and OT antagonist [d(CH2)5,Tyr(Me)2,Thr4,Tyr-
NH29]ornithine vasotocin from Peninsula Laboratories (Bel-
mont, CA); pertussis toxin, GF-109203X, 1,2-bis(2-aminophen-
oxy)ethane-N,N,N,N-tetraacetic acid-AM (BAPTA-AM),
genestein, wortmannin, and phorbol 12-myristate 13-acetate
(PMA) from Biomol Research Laboratories (Plymouth Meet-
ing, PA); FBS from Atlanta Biological (Atlanta, GA); MEM
and cell culture reagents from GIBCO-BRL (Grand Island,
NY). All other chemicals were obtained from Sigma (St.
Louis, MO).
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Myometrial cell culture. The University of Texas Medical
Branch Committee on Research Involving Human Subjects
approved the use of human tissue. Myometrial samples were
taken from women by caesarean section near the end of
gestation, and cells were prepared as described previously
(5). The cells were maintained in MEM containing 10%
(vol/vol) FBS, 1 mM sodium pyruvate, 2 mM L-glutamine, 100
IU/ml penicillin G, 100 g/ml streptomycin sulfate, and 15
g/ml amphotericin B at 37°C (95% humidity) in the pres-
ence of 5% CO2. The cells, which were used at confluence
between passages 3 and 10, were serum starved overnight
(about 16 h) before treatment with OT or other agents.
Northern blot analysis. Total RNA was isolated from cul-
tured human myometrium cells using TRIzol reagent
(GIBCO-BRL Life Technologies, Rockville, MD). Samples of
20 g of RNA were subjected to electrophoresis in 1% aga-
rose-formaldehyde gels and transferred to nylon membranes
for Northern blotting. The RGS2 probe was obtained by
RT-PCR and cloned into pGEM-T Easy (Promega, Madison,
WI). We identified selected clones by restriction enzyme di-
gestion and DNA sequencing. Hybridizations were performed
using random primed cDNA fragments of the entire coding
regions of RGS2 gene labeled with [-32P]dCTP (3,000 Ci/
mmol; Amersham Pharmacia Biotech, Piscataway, NJ) in
ExpressHyb hybrization solution (Clontech Laboratories,
Palo Alto, CA) overnight at 68°C. The blots were rinsed for 10
min at room temperature with 1 saline-sodium citrate
(SSC) and 0.1% SDS solution and then 45 min at 65°C with
0.2 SSC and 0.1% SDS solution. The blots were exposed to
a Cyclone phosphor screen (Packard Instrument, Meriden,
CT) for image analysis and to X-ray film at 80°C for 1–3
days. After the films were developed, the nylon membranes
were stripped and reprobed with the human -tubulin cDNA,
which was synthesized by RT-PCR, cloned, and labeled by
random priming as described for the RGS2 probe.
Analysis of data. Experiments were repeated on myome-
trial cells derived from three separate women. The results of
the Northern blots were analyzed densitometrically and
quantified using ImageQuant software (Packard Instru-
ment). In cases where a percent change is reported, the
values were obtained by expressing the RGS2 mRNA concen-
tration relative to that of -tubulin mRNA. Because of vari-
ability in the results between cells in primary culture from
different patients, the data are presented as a representative
Northern blot from a triplicate set. The changes in RGS2
expression within each treatment group were comparable in
all cases.
RESULTS
OT specifically increases RGS2 mRNA expression.
Treatment of human myometrial cells with 100 nM OT
resulted in an increase in the amount of RGS2 mRNA
by 30 min (Fig. 1). Maximal stimulation was apparent
by 1–2 h (Fig. 1). An effect of OT at 2 h was seen with
as little as 0.1 nM OT, and 1 nM OT gave a near-
maximal response (Fig. 2A). The effects of OT were
blocked by the OT antagonist (Fig. 2B).
Mediators in OT-stimulated RGS2 mRNA expres-
sion. OT signaling in the myometrium has been shown
to occur via Gq/phospholipase C (PLC) and activation of
protein kinase C (PKC; see Refs. 9, 21, 24). Treatment
of myometrial cells with the Ca2 ionophore A-23187
(50 M) to elevate intracellular Ca2 concentrations
resulted in an increase in RGS2 mRNA levels, with a
maximal increase at 2 h (Fig. 3A). A-23187 treat-
ment, however, caused the degradation of mRNA at
later time points, as was apparent by -tubulin anal-
ysis (Fig. 3A). Increases in intracellular Ca2 concen-
trations generated by OT treatment appear to be re-
sponsible for OT-stimulated expression of RGS2
mRNA, as pretreatment of cells with the Ca2 chelator
BAPTA-AM (10 and 30 M) blocked the effects of OT
(Fig. 3B). The effects of A-23187 treatment were also
blocked by the two concentrations of BAPTA-AM (Fig.
3B).
OT signaling through stimulation of PLC activity
results in activation of PKC. Activation of PKC by PMA
also stimulated an increase in RGS2 mRNA 2 h after
treatment (Fig. 4). This effect was blocked by pretreat-
ment with the PKC inhibitor GF-109203X, at 1 and 10
M. The effects of OT on RGS2 mRNA levels, however,
were only partially blocked by the same doses of GF-
109203X.
Increases in intracellular cAMP have been shown to
induce increases in RGS2 mRNA levels in certain cell
types but not others. Elevation of intracellular cAMP
concentration by forskolin treatment caused a marked
increase in RGS2 mRNA levels (Fig. 5). Thus human
myometrial cells are in the category of cell type that
responds to cAMP with an increase in RGS2 mRNA
expression.
Fig. 1. Northern blot analysis of the effects of oxytocin (100 nM) on
regulator of G protein (RGS2) mRNA levels in cultured human
myometrial cells. After analysis, the blots were reprobed to deter-
mine -tubulin mRNA concentration, which was used to normalize
RGS2 mRNA levels. -TUB, -tubulin.
Fig. 2. Specificity of the RGS2 mRNA response to oxytocin (OT). A:
dose-response relationship between OT concentration and RGS2
mRNA levels. Cells were treated with OT for 2 h. B: inhibition of the
OT-stimulated RGS2 mRNA response by OT antagonist (OTA). Cells
were treated either with 10 nM OT, 100 nM OT antagonist, or both
for 2 h.
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Synergy between signal pathway activators on RGS2
expression. The effects of A-23187 and PMA were po-
tentiated by cotreatment with forskolin (Fig. 6). Like-
wise, A-23187 synergized with PMA to enhance RGS2
mRNA expression. The effects of PMA in conjunction
with either A-23187 or forskolin were notable in that
PMA alone was not stimulatory at the time point
taken. The findings indicate that RGS2 mRNA levels
are regulated along separate and complementary path-
ways with respect to increased intracellular Ca2 con-
centrations, activation of PKC, and elevation of intra-
cellular cAMP levels.
Other potential pathways mediating OT stimulation
of RGS2 mRNA expression. The effects of OT on stim-
ulation of inositol trisphosphate and increased intra-
cellular Ca2 concentrations are mediated by both per-
tussis toxin-sensitive and -insensitive pathways (25).
Pretreatment of human myometrial cells with pertus-
sis toxin (either 200 or 400 ng/ml) for 18 h blunted the
increase in RGS2 expression stimulated by 2 h of
treatment with OT (Fig. 7). There was a 32–51% re-
duction in OT-stimulated RGS2 expression with per-
tussis toxin treatment. These findings indicate that a
portion of the effects of OT on RGS2 mRNA are medi-
ated by Gi/o. Agonists for receptors coupled to Gi/o have
been shown to cross-talk through G	 to nonreceptor
and receptor tyrosine kinase pathways (17). In keeping
with the pertussis toxin effect, pretreatment of human
myometrial cells with the tyrosine kinase inhibitor
genestein (25 and 50 M) for 2 h also partially inhib-
ited (28–40%) the stimulation of RGS2 mRNA expres-
sion by 100 nM OT (Fig. 7).
DISCUSSION
The RGS2 mRNA expression in human myometrial
cells in primary culture was elevated in the presence of
10% FBS, but it was substantially diminished after
18 h of serum deprivation. Subsequent treatment of
cells with OT caused a marked increase in RGS2
mRNA levels after 1 or 2 h, with a rise that was obvious
after 30 min. Near-maximal effects were obtained with
1 nM OT, which is near the EC50 value for OT stimu-
lation of intracellular Ca2 and inositol phosphate el-
evation in human myometrial cells in primary culture
(25). These findings indicate that the effects of OT on
RGS2 mRNA are physiologically relevant. The effects
of OT were ligand specific, since the OT antagonist
blocked the rise in RGS2 mRNA levels.
There is still relatively little known about what reg-
ulates different RGS proteins. Based on the limited
data available, the signal pathways involved in RGS2
mRNA expression appear to depend on cellular con-
text. In human neuroblastoma SH-SY5Y cells, RGS2
mRNA levels are increased by activation of muscarinic
receptors and a PKC-dependent mechanism (26). The
RGS2 expression was not affected by increases in ei-
ther intracellular Ca2 or cAMP concentrations. PKC
also appears to mediate RGS2 mRNA increases by
ANG II in vascular smooth muscle cells (11). Tyrosine
kinase inhibition and Ca2 deprivation did not affect
this increase in RGS2 mRNA concentration. A greater
increase was seen in levels of RGS1 mRNA in human B
Fig. 3. Involvement of intracellular Ca2 concentration on OT-stim-
ulated RGS2 mRNA expression. A: effect of Ca2 ionophore A-23187
after 2 h of treatment. B: effect of 1,2-bis(2-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid-AM (BAPTA-AM) pretreatment on
A-23187- and OT-stimulated RGS2 mRNA expression.
Fig. 4. Effect of protein kinase C (PKC) activation by phorbol 12-
myristate 13-acetate (PMA; 100 nM) and inhibition of PKC activity
by GF-109203X (1 and 10 M) on RGS2 mRNA expression. Cells
were pretreated with inhibitor for 30 min, followed by treatment
with either PMA or OT (100 nM) for 2 h.
Fig. 5. Effect of forskolin (FSK; 25 M) on RGS2 mRNA expression
in human myometrial cells.
Fig. 6. Synergistic effects of A-23187 (50 M), forskolin (25 M), and
PMA (100 nM) on RGS2 mRNA expression. Cells were treated for
2 h.
E582 OXYTOCIN-STIMULATED RGS2 MRNA EXPRESSION
AJP-Endocrinol Metab • VOL 282 • MARCH 2002 • www.ajpendo.org
lymphocytes in response to a PKC activator than to a
Ca2 ionophore (ionomycin), whereas the opposite was
true for RGS2 mRNA synthesis in blood mononuclear
cells (13). Elevation of intracellular cAMP induces
RGS2 expression in cultured rat osteoblasts (19) and
PC-12 cells (22). Thus, depending on the cell type,
RGS2 expression can be induced exclusively by PKC,
intracellular Ca2, or cAMP. Each one of these path-
ways mediates the actions of G protein-coupled recep-
tors and likely contributes to feedback regulation of the
G proteins involved.
As we have shown in our present studies, there are
multiple pathways that lead to increased RGS2 mRNA
levels in human myometrial cells (Fig. 8). The primary
signal that mediates the effects of OT appears to be
linked to PLC-mediated stimulation of intracellular
Ca2 concentrations. OT also activates PKC via PLC-
stimulated increases in diacylglycerol concentration.
PKC likely catalyzes the phosphorylation of specific
proteins that are involved in increased RGS2 mRNA
levels. Partial inhibition of the effects of OT on RGS2
mRNA expression by pertussis toxin indicates that Gi/o
plays a role in signaling increases in RGS2 mRNA
levels. In view of the similar degree of inhibition
caused by pertussis toxin and genestein, we speculate
that G	 linked to tyrosine kinase activation mediates
a portion of the OT effect on RGS2 mRNA expression.
This type of transactivation by G	 has been described
in other G protein-coupled receptor systems (16, 17).
Increases in intracellular cAMP concentrations also
caused a rise in RGS2 mRNA levels, presumably inde-
pendent of the OT receptor, which is not coupled to Gs.
cAMP produces relaxation of smooth muscle by activa-
tion of cAMP-dependent protein kinase A, which inter-
feres with several processes involved in smooth muscle
contraction (3, 30). We speculate that there is the
potential for heterologous regulation of OT action by
agents that generate intracellular cAMP. The resulting
increase in RGS2 expression might attenuate the re-
sponses to OT or other uterotonins acting via G pro-
teins. Agents that increase myometrial cell cAMP lev-
els include -adrenergic drugs (15), relaxin (18),
corticotropin-releasing hormone (10), calcitonin gene-
related peptide (1), adrenomedullin (1), and parathy-
roid hormone-related peptide (29), among others.
The role of RGS2 in myometrial cell function re-
mains to be established. It has been tacitly assumed
that RGS2 functions as a GTPase. Thus an increase in
RGS2 protein levels after an initial stimulation might
be expected to attenuate subsequent signaling. In sup-
port of this possibility, Phaneuf and coworkers (23)
found that exposing cultured human myometrial cells
to OT for a prolonged period caused desensitization of
the response to OT. There was a concomitant 90%
reduction in the number of high-affinity receptor bind-
ing sites. Immunoblot and flow cytometry data indi-
cated, however, that the total amount of OT receptor
protein on the cell membrane surface was unaffected
by OT treatment. These findings suggest that desensi-
tization could occur at the G protein level (possibly
involving RGS2) rather than at the receptor level.
Recent studies have indicated that RGS2 phosphor-
ylation, along with RGS2 protein synthesis, may also
be an important means of regulating GTPase activity.
Phosphorylation of RGS2 by PKC in vitro diminished
RGS2 activity stoichiometrically (28). There is evi-
dence that RGS2 also has functions that are not asso-
ciated with GTPase activity. RGS2 inhibits cAMP pro-
duction by directly inhibiting the activity of adenylyl
cyclase type III, the predominant adenylyl cyclase iso-
form in olfactory neurons (4). Although a clear under-
standing of the role in RGS2 mRNA in human myome-
trial cells remains to be established, the profound
changes in RGS2 mRNA concentration elicited by OT
suggest that RGS2 serves an important regulatory
function with respect to OT action in these cells. Up-
regulation of RGS2 mRNA has also been demonstrated
in vivo, in ovarian granulosa cells after human chori-
onic gonadotropin treatment (27). Because the myome-
trium undergoes marked changes in sensitivity to OT
during pregnancy (6, 7), future studies are needed to
Fig. 7. Inhibition of OT-stimulated RGS2 mRNA expression by per-
tussis toxin (PTx) and genestein (Gen), a tyrosine kinase inhibitor.
The myometrial cells were pretreated with either pertussis toxin for
18 h or with genestein for 30 min before treatment with OT for 2 h.
Fig. 8. Summary of multiple pathways involved in upregulating
RGS2 mRNA expression in human myometrial cells in primary
culture. The primary signal mediating the effects of OT was an
elevation in intracellular Ca2 concentration. PKC activation ap-
peared to be secondary. Independent of the effects of OT, forskolin
(which elevates intracellular cAMP concentrations) also increased
RGS2 mRNA expression. About one-half of the OT effect is mediated
by Gi/o and tyrosine kinase activity, as reflected by inhibition by
pertussis toxin and genestein, respectively. Tyrosine kinase activa-
tion has been shown in other systems to be coupled to Gi activation,
presumably through G	 interactions. OTR, OT receptor; PLC, phos-
pholipase C; DAG, diacylglycerol; PKA, protein kinase A; InsP3,
inositol trisphosphate.
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elucidate the importance of RGS2 in the responsive-
ness of the myometrium to OT in vivo.
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